Resources

26
Mar

POSTER – SOT HypoSkin Pharma Latch

Intradermal device testingA collaboration study with Pharma LatchReplacing animal testing in local tolerance assessment of an injection device: Human ex vivo HypoSkin® model as a New Approach Methodology (NAM) Jérémy Argenty1, Clémence Letzelter1, Catherine Marques1, Sophie Abadie1, Alexia Sanchez1, Claire Gendrin1, Alexandra Ochando1, Adam Rock2, Ronan Byrne2, Pascal Descargues1, Nicky Bertollo2 1Genoskin, 2Pharma Latch HypoSkin® is an ex vivo human skin NAM that
Read more
26
Mar

POSTER – SOT Hyposkin argenx

Local toxicity & Formulation safetyA collaboration study with argenxHypoSkin® as a human-based NAMs platform for local toxicity and formulation safety assessment Julie Magerman1, Katarzyna Polak2, Ornella Binazon1, Michael Pastore2, Alexandra Ochando2, Judith Baumeister1 1argenx, 2Genoskin Formulation safety testing still relies heavily on in vivo studies due to limited validated in vitro alternatives. Genoskin’s HypoSkin® biostabilized ex vivo human skin enables multi-parametric local tolerance assessment after subcutaneous injection.
Read more
18
Mar

Genoskin collaboration with argenx

Genoskin & argenx showcasehuman-based NAM platformPress releaseGenoskin presents translational human-based NAM platform at SOT 2026 in collaboration with argenxAdvancing New Approach Methodologies (NAMs) with human skin modelsAt the 2026 annual meeting of the Society Of Toxicology (SOT), we will present new data demonstrating the value of our HypoSkin® ex vivo human skin platform as a translational human-based New Approach Methodology
Read more
17
Feb

WEBINAR #15: Preclinical evaluation of an energy-driven device for localized skin delivery of nucleic acids

Top-level science through the eyes of an expert.Preclinical evaluation of an energy-driven device for localized skin delivery of nucleic acidsDid you miss the live session? The full webinar recording is now available to watch on demand. Explore preclinical insights into an energy-driven, microneedle-based device enabling localized, non-viral delivery of naked nucleic acids to skin, highlighting transgene expression, immune activation, and
Read more
2
Feb

APPLICATION NOTE – NativeSkin® & UV testing

Explore how NativeSkin® supports ethical, human-relevant, and translational research in UV testing, phototoxicity assessment, and photobiology.

29
Jan

Rethinking wound healing: from classical readouts to emerging ways of studying tissue repair

Rethinking wound healing: from classical readouts to emerging ways of studying tissue repairEvery day, our skin quietly repairs itself after injury, a process that relies on a complex regenerative program. In this blog, we explore what drives effective wound repair, why some wounds fail to heal, and what it takes to translate laboratory insights into meaningful clinical outcomes.Wound healing: biological
Read more